Peijia Medical (Germany) Performance
| 4WO Stock | EUR 0.53 0.01 1.85% |
On a scale of 0 to 100, Peijia Medical holds a performance score of 6. The company holds a Beta of -0.0909, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Peijia Medical are expected to decrease at a much lower rate. During the bear market, Peijia Medical is likely to outperform the market. Please check Peijia Medical's semi deviation, jensen alpha, maximum drawdown, as well as the relationship between the coefficient of variation and sortino ratio , to make a quick decision on whether Peijia Medical's historical price patterns will revert.
Risk-Adjusted Performance
Modest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Peijia Medical Limited are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Peijia Medical reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 2.5 B |
Peijia |
Peijia Medical Relative Risk vs. Return Landscape
If you would invest 46.00 in Peijia Medical Limited on December 16, 2024 and sell it today you would earn a total of 7.00 from holding Peijia Medical Limited or generate 15.22% return on investment over 90 days. Peijia Medical Limited is currently producing 0.2864% returns and takes up 3.329% volatility of returns over 90 trading days. Put another way, 29% of traded stocks are less volatile than Peijia, and 95% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Peijia Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Peijia Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Peijia Medical Limited, and traders can use it to determine the average amount a Peijia Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.086
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 4WO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.33 actual daily | 29 71% of assets are more volatile |
Expected Return
| 0.29 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average Peijia Medical is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Peijia Medical by adding it to a well-diversified portfolio.
Peijia Medical Fundamentals Growth
Peijia Stock prices reflect investors' perceptions of the future prospects and financial health of Peijia Medical, and Peijia Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Peijia Stock performance.
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0574 | |||
| Profit Margin | (2.41) % | |||
| Operating Margin | (1.51) % | |||
| Current Valuation | 490.84 M | |||
| Shares Outstanding | 677.41 M | |||
| Price To Book | 1.79 X | |||
| Price To Sales | 3.61 X | |||
| Revenue | 136.53 M | |||
| EBITDA | (574.03 M) | |||
| Cash And Equivalents | 2.46 B | |||
| Cash Per Share | 3.90 X | |||
| Total Debt | 9.13 M | |||
| Debt To Equity | 0 % | |||
| Book Value Per Share | 4.39 X | |||
| Cash Flow From Operations | (436.37 M) | |||
| Earnings Per Share | (0.10) X | |||
| Total Asset | 3.16 B | |||
About Peijia Medical Performance
By analyzing Peijia Medical's fundamental ratios, stakeholders can gain valuable insights into Peijia Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Peijia Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Peijia Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Peijia Medical Limited engages in the research, development, production, and sales of interventional procedural medical devices for the treatment of structural heart and neurovascular diseases. Peijia Medical Limited was founded in 2012 and is headquartered in Suzhou, the Peoples Republic of China. PEIJIA MEDICAL operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 389 people.Things to note about Peijia Medical performance evaluation
Checking the ongoing alerts about Peijia Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Peijia Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Peijia Medical has some characteristics of a very speculative penny stock | |
| Peijia Medical had very high historical volatility over the last 90 days | |
| The company reported the revenue of 136.53 M. Net Loss for the year was (574.22 M) with profit before overhead, payroll, taxes, and interest of 95.65 M. | |
| Peijia Medical Limited has accumulated about 2.46 B in cash with (436.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.9, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 30.0% of the company shares are owned by insiders or employees |
- Analyzing Peijia Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Peijia Medical's stock is overvalued or undervalued compared to its peers.
- Examining Peijia Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Peijia Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Peijia Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Peijia Medical's stock. These opinions can provide insight into Peijia Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Peijia Stock analysis
When running Peijia Medical's price analysis, check to measure Peijia Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Peijia Medical is operating at the current time. Most of Peijia Medical's value examination focuses on studying past and present price action to predict the probability of Peijia Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Peijia Medical's price. Additionally, you may evaluate how the addition of Peijia Medical to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |